Medicare Prescription Drug Cost Containment Act of 2005

The Medicare Prescription Drug Cost Containment Act of 2005 (S. 581) was designed to establish a financial oversight mechanism for the Medicare Part D prescription drug program. The bill would have required the Secretary of Health and Human Services to issue a formal "funding warning" if the program’s costs exceeded a specific threshold of general federal tax revenue. If such a warning were triggered, the President would be legally required to propose legislation to reduce spending, and Congress would be required to consider that legislation under expedited procedures.

For everyday citizens, this bill aimed to prevent the Medicare drug benefit from becoming a larger burden on the federal budget than originally projected. While it did not directly change drug prices or benefits, it created a process that could lead to future changes in how the program is funded or administered if costs rose too quickly. The bill was referred to the Committee on Finance but did not advance further in the legislative process.